Healthcare
For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come
For the final 10% of cystic fibrosis patients who cannot benefit from breakthrough drugs, Emily's Entourage is funding research to find treatments.
Keyword
Fibrosis
1 stories in the last 7 days. Coverage in the last day was about normal.
- 7-day mood
- —Not enough data
- Stories, 7 days
- 1
- Last 24 hours
- 1no baseline yet
- Sources
- 2in the latest 2
Mood and coverage · last 7 days
Market chart- Fibrosis · 6-hour average
- Hourly reading
- Stories per hour
View as table
| Day | Mood | Stories |
|---|---|---|
| Fri, Oct 9 | — | 1 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
| Sat, Oct 3 | — | 0 |
| Fri, Oct 2 | — | 0 |
Latest on Fibrosis
Newest firstHealthcare
Akero's EFX Shows Significant Fibrosis Reversal In MASH Cirrhosis At 96 Weeks
(RTTNews) - Akero Therapeutics (AKRO) unveiled new data from its Phase 2b SYMMETRY trial highlighting the potential of efruxifermin - EFX to reverse fibrosis i…
